Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease

Giuseppe G L Biondi-Zoccai1, Antonio Abbate, Fortunata Vasaturo

  • 1Institute of Cardiology, Catholic University, Rome, Italy.

Insights

Multivessel coronary disease after heart attack increases myocardial apoptosis (programmed cell death) in remote heart regions. This cell loss, potentially due to ongoing ischemia, contributes to poor outcomes in patients with multivessel coronary disease.

Area of Science:

  • Cardiovascular pathology
  • Myocardial infarction research
  • Cellular apoptosis mechanisms

Background:

  • Multivessel coronary disease (MVD) post-myocardial infarction (MI) is linked to adverse cardiac remodeling and mortality.
  • Underlying mechanisms, particularly post-MI myocardial apoptosis, are not fully understood.
  • Apoptosis in non-infarcted regions may contribute to ongoing cell loss and cardiac dysfunction.

Purpose of the Study:

  • To investigate the role of post-infarction myocardial apoptosis in the remote myocardium of patients with MVD.
  • To assess the expression of pro-apoptotic factors in relation to MVD after MI.
  • To determine if MVD influences cell death in viable, non-infarcted heart tissue.

Main Methods:

  • Autopsy study of 21 male patients with recent MI and occluded infarct-related artery.
  • Apoptosis assessed via DNA fragmentation and cleaved caspase-3 staining in remote myocardium.
  • Immunohistochemistry used to evaluate pro-apoptotic factor (Bax) and hypoxia-induced factor-1alpha expression.

Main Results:

  • MVD patients (N=11) exhibited significantly higher myocardial apoptosis (0.9%) compared to single-vessel disease patients (N=10, 0.5%).
  • Bax expression was also significantly increased in MVD patients (3.0%) versus single-vessel disease patients (1.4%).
  • Apoptotic rates correlated with the extent of coronary artery disease and remained predictive of apoptosis even >30 days post-MI.

Conclusions:

  • Post-infarction myocardial apoptosis and Bax expression are elevated in the remote myocardium of male patients with MVD.
  • These findings suggest apoptotic cell loss in viable myocardium, possibly from ischemia, contributes to the poor prognosis in MVD post-MI.
  • Targeting apoptosis may be a therapeutic strategy for patients with MVD after myocardial infarction.
Abstract